Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kracie Pharma Korea is the South Korean subsidiary of the Japanese pharmaceutical company Kracie Pharma, Ltd. The company specializes in the distribution and marketing of Kampo medicines, which are traditional Japanese herbal formulations standardized for modern clinical use. Their product portfolio in Korea primarily focuses on over-the-counter (OTC) and prescription herbal extracts targeting common ailments such as respiratory infections, digestive disorders, and physical fatigue. By leveraging the extensive R&D and manufacturing heritage of its Japanese parent, Kracie Pharma Korea provides high-quality, evidence-based traditional medicine to the Korean healthcare market. The company is recognized for its convenient granule-type formulations that improve patient compliance compared to traditional liquid decoctions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kracie Pharma Korea.